Clinical Researcher—May 2019 (Volume 33, Issue 5) GOOD MANAGEMENT PRACTICE Christopher J. Ianelli, MD, PhD; Andy Olen, MBA No one likes waste. We close our windows when the AC is on. We invest our savings. We recycle our grocery packaging so the material can be used once again. How, then, can we in the medical community discard untold volumes of human blood, urine, and other biofluid specimens that flow through U.S. clinical labs every year—specimens that researchers desperately need? We can’t. Or at least we shouldn’t. Biospecimens for science can be difficult to procure and, as a result, researchers are forced to postpone their vital work on new therapeutics and diagnostics until the appropriate specimens can be acquired. Moreover, in this era of precision medicine, researchers’ needs are getting only more specific. Instead of requiring 50 generic blood samples, they may need 50 plasma samples from patients with myeloid leukemia … Continue reading Extracting Scientific and Economic Value from Clinical Remnants